J2403 HCPCS code: Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
J2403 is the HCPCS Level II code for chloroprocaine hcl ophthalmic, 3% gel, 1 mg. In 2024 Medicare paid an average of $0.51 per service for J2403 across 73,644,452 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1600 per day on outpatient hospital claims. Medicare volume rose 557% from 2023 to 2024 (11,204,225 to 73,644,452 services). In 2024, about 289 clinicians billed Medicare for J2403 for 37,801 beneficiaries; Maryland, Florida, New Jersey accounted for 42% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-04-01 |
| Last action effective | 2023-04-01 |
Who bills J2403 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 289 |
| Medicare beneficiaries | 37,801 |
| States with claims | 37 |
| Share of services in top 3 states (Maryland, Florida, New Jersey) | 42% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2403, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 11,204,225 | 8,458 | $0.69 | $0.55 |
| 2024 | 73,644,452 | 37,801 | $0.64 | $0.51 |
States with the most J2403 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Maryland | 15,052,123 | $0.51 |
| Florida | 8,426,993 | $0.51 |
| New Jersey | 7,119,119 | $0.51 |
| Missouri | 6,448,175 | $0.51 |
| Tennessee | 3,895,812 | $0.50 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1600 | Anatomic Consideration |
| practitioner claims | 1600 | Anatomic Consideration |
What changed for J2403
- 2023-04-01: J2403 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2403?
J2403 is the HCPCS Level II code for chloroprocaine hcl ophthalmic, 3% gel, 1 mg. Short descriptor: "Chloroprocaine opht gel, 1mg".
How much does Medicare pay for J2403?
In 2024, the average Medicare payment was $0.51 per service (average allowed $0.64).
Does Medicare cover J2403?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2403 can be billed per day?
1600 on outpatient hospital claims; 1600 on practitioner claims (NCCI medically unlikely edits).
Related J24 codes
- J2400 — Injection, chloroprocaine hydrochloride, per 30 ml
- J2401 — Injection, chloroprocaine hydrochloride, per 1 mg
- J2402 — Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2404 — Injection, nicardipine, 0.1 mg
- J2405 — Injection, ondansetron hydrochloride, per 1 mg
- J2406 — Injection, oritavancin (kimyrsa), 10 mg
- J2407 — Injection, oritavancin (orbactiv), 10 mg
- J2410 — Injection, oxymorphone hcl, up to 1 mg
- J2425 — Injection, palifermin, 50 micrograms
- J2426 — Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427 — Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428 — Injection, paliperidone palmitate extended release (erzofri), 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2403
- Watch J2403 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2403
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.